Pseudohyperkalemia: A new twist on an old phenomenon.

Crit Rev Clin Lab Sci

Department of Laboratory Medicine, MD Anderson Cancer Center, The University of Texas, Houston, TX , USA.

Published: February 2016

Severe hyperkalemia is a potentially life-threatening condition requiring immediate medical intervention. Pseudohyperkalemia can be misleading and result in incorrect interpretation and inappropriate patient management. Immediate recognition and appropriate interpretation of pseudohyperkalemia, on the other hand, prevents misdiagnosis and unnecessary intervention. Pseudohyperkalemia is induced by hemolysis and excessive leakage of potassium from cells during or after blood collection. It has been increasingly seen in many hematological disorders such as leukocytosis and thrombocytosis. Reverse pseudohyperkalemia has recently been reported in leukemic patients in whom the plasma potassium levels are greater than the serum potassium levels because of heparin-induced cell membrane damage. Although pseudohyperkalemia has long been recognized and understood, it continues to be misinterpreted. To improve patient care, an algorithm for investigation of pseudohyperkalemia and preventive measures should be established and implemented in the clinical laboratory.

Download full-text PDF

Source
http://dx.doi.org/10.3109/10408363.2014.966898DOI Listing

Publication Analysis

Top Keywords

intervention pseudohyperkalemia
8
potassium levels
8
pseudohyperkalemia
7
pseudohyperkalemia twist
4
twist phenomenon
4
phenomenon severe
4
severe hyperkalemia
4
hyperkalemia life-threatening
4
life-threatening condition
4
condition requiring
4

Similar Publications

Objectives: In most countries the majority of patients are in outpatient care. In difference to hospitalized patients, their blood samples often take hours after collection to centrifugation. The study investigates the release of potassium and the development of pseudohyperkalemia in lithium heparin (Li-Hep) and serum blood collection tubes over time.

View Article and Find Full Text PDF
Article Synopsis
  • Hyperkalaemia is a serious medical emergency that requires immediate treatment, but there is uncertainty about the exact level at which treatment should start due to different clinical situations.
  • The case report focuses on an 89-year-old man with frequent falls and unstable potassium levels, who did not exhibit symptoms of hyperkalaemia and lacked a significant drug history.
  • Further examination identified a myeloproliferative neoplasm causing thrombocytosis, leading to a diagnosis of pseudohyperkalaemia, which emphasizes the importance of distinguishing between true hyperkalaemia and pseudohyperkalaemia in patients with blood disorders.
View Article and Find Full Text PDF
Article Synopsis
  • Pseudohyperkalemia, a condition characterized by falsely high potassium levels, can be confused with true hyperkalemia, leading to unnecessary treatments; it is important to differentiate between the two.
  • A study analyzed 1188 blood samples and found that pneumatic tube transportation was associated with a higher occurrence of pseudohyperkalemia, particularly when white blood cell (WBC) counts were elevated (≥ 100 × 10/μL).
  • The results indicate that for every increase of 100 × 10/μL in WBC count, the likelihood of pseudohyperkalemia increased significantly (multiplied by 3.75), suggesting that careful sample handling is crucial for accurate potassium level assessment
View Article and Find Full Text PDF

Patients with newly diagnosed hematological malignancies often present with a considerable cellular burden, leading to complications including hyperkalemia. However, pseudohyperkalemia, arising from cell lysis, can pose challenges in clinical practice. Although pseudohyperkalemia is frequently reported in adult hematological malignancies, its occurrence in pediatric patients is underreported, and its incidence in this demographic remains unclear.

View Article and Find Full Text PDF

Objective: To investigate pseudohyperkalemia occurring in horses experiencing rhabdomyolysis when serum chemistry profiles are run on an VetScan VS2 analyzer (Abaxis).

Animals: 18 horses with rhabdomyolysis (creatine kinase [CK] > 1,000 U/L).

Methods: In 3 horses with serum CK activities > 5,800 U/L and persistent serum potassium concentrations of > 8.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!